2.68

2.29% +0.06

After Hours: 2.75 0.07 +2.61%

Nuvation Bio Inc (NUVB)

Overview News Price History Option Chain Discussions Forecast

Nuvation Bio Inc stock is currently priced at $2.68, with a 24-hour trading volume of 633.20K. It has seen a +2.29% increased in the last 24 hours and a -6.94% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $2.60 pivot point. If it approaches the $2.72 resistance level, significant changes may occur.

Previous Close:

$2.62

Open:

$2.63

24h Volume:

633.20K

Market Cap:

$661.23M

Revenue:

Net Income/Loss:

$-75.80M

P/E Ratio:

-6.5366

EPS:

-0.41

Net Cash Flow:

$-68.07M

1W Performance:

+3.08%

1M Performance:

-6.94%

6M Performance:

+139.29%

1Y Performance:

+63.41%

1D Range:

$2.61

$2.76

52W Range:

$0.95

$4.1598

Nuvation Bio Inc Stock (NUVB) Company Profile

Name

Nuvation Bio Inc

Sector

Healthcare (1191)

Industry

Biotechnology (688)

Phone

650-245-3818

Address

1500 Broadway, Suite 1401, New York

Employee

Twitter

Next Earnings Date

2024-05-02

Latest SEC Filings

NUVB's Discussions on Twitter

Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-06-23	Downgrade	Jefferies	Buy → Hold
Aug-02-22	Downgrade	BMO Capital Markets	Outperform → Market Perform
Aug-02-22	Downgrade	BTIG Research	Buy → Neutral
May-04-22	Initiated	H.C. Wainwright	Buy
Oct-15-21	Resumed	BTIG Research	Buy
Apr-06-21	Initiated	RBC Capital Mkts	Outperform
Mar-08-21	Initiated	BMO Capital Markets	Outperform
Mar-08-21	Initiated	BTIG Research	Buy
Mar-08-21	Initiated	Cowen	Outperform
Mar-08-21	Initiated	Jefferies	Buy
Mar-08-21	Initiated	Wedbush	Outperform

View All

Nuvation Bio Inc Stock (NUVB) Latest News

Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Benzinga

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday

Benzinga

Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Benzinga

Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket

Benzinga

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Nuvation Bio Inc Stock (NUVB) Financials Data

Nuvation Bio Inc (NUVB) Net Income 2024

NUVB net income (TTM) was -$75.80 million for the quarter ending December 31, 2023, a +27.25% increase year-over-year.

Nuvation Bio Inc (NUVB) Cash Flow 2024

NUVB recorded a free cash flow (TTM) of -$68.07 million for the quarter ending December 31, 2023, a +29.45% increase year-over-year.

Nuvation Bio Inc (NUVB) Earnings per Share 2024

NUVB earnings per share (TTM) was -$0.35 for the quarter ending December 31, 2023, a +27.08% growth year-over-year.

Nuvation Bio Inc., a biopharmaceutical company, focuses on the development of therapies for oncology. Its portfolio includes various oncology programs with multiple drug development candidates. Nuvation Bio Inc.was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. The company was founded in 2018 and is based in New York, New York with an additional office in San Francisco, California.